BRIEF published on 05/14/2024 at 08:05, 6 months 7 days ago VERBIO Reports Downturn in Q3 Earnings Amid Volatile Market Conditions Market Volatility EBITDA Decrease VERBIO Financial Results Growth Projects In USA Biofuel Sales Decline
PRESS RELEASE published on 05/14/2024 at 08:00, 6 months 7 days ago Q3 2023/24: Volatile market environment affects earnings Verbio SE reports decrease in earnings for Q3 2023/24 due to volatile market conditions, with expectations of significant improvement in Q4 2023/24 Volatility Market Environment Earnings Verbio SE Q3 2023/24
PRESS RELEASE published on 02/08/2024 at 08:00, 9 months 13 days ago Q2 2023/24: Verbio holds its own in a volatile market environment Verbio SE reports solid performance in Q2 2023/24 despite challenging market conditions. Group revenue reaches EUR 908.9 million, EBITDA at EUR 74.9 million. Net financial debt at EUR 13.6 million EBITDA Financial Report Market Conditions Verbio SE Q2 2023/24
PRESS RELEASE published on 09/28/2023 at 11:48, 1 year 1 month ago VERBIO Vereinigte BioEnergie AG: VERBIO Capital Markets Day 2023: Global growth and value added continue
PRESS RELEASE published on 09/26/2023 at 08:10, 1 year 1 month ago VERBIO Vereinigte BioEnergie AG: FY 2022/2023: Second-best results in the history of VERBIO
PRESS RELEASE published on 09/26/2023 at 08:03, 1 year 1 month ago EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO forecasts EBITDA of EUR 200 million to EUR 250 million for the financial year 2023/24.
PRESS RELEASE published on 08/25/2023 at 16:30, 1 year 2 months ago VERBIO Vereinigte BioEnergie AG: Virtual extraordinary general meeting approves a resolution for conversion into an SE (Societas Europaea)
PRESS RELEASE published on 05/11/2023 at 08:00, 1 year 6 months ago VERBIO Vereinigte BioEnergie AG: Recovery in Bioethanol segment leads to solid Q3 2022/23 earnings
PRESS RELEASE published on 05/01/2023 at 17:58, 1 year 6 months ago EQS-Adhoc: VERBIO Vereinigte BioEnergie AG: VERBIO acquires an ethanol plant from Mercuria in South Bend/Indiana, USA.
Published on 11/21/2024 at 13:30, 20 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 20 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 50 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 50 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 50 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 15 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 35 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
